Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination

Background Data on the current burden of adenocarcinoma (ADC) and histology-specific human papillomavirus (HPV) type distribution are relevant to predict the future impact of prophylactic HPV vaccines.